Table 2. Evaluation of antibacterial and cytotoxicity activity of propargyl-linked antifolates.
Cmpd # | MICMRSAa | MICMRSAb+FCS | MICS.pyogenes | MICS. pyogenes+FCSc | IC50MCF-10(µM) | IC50 HepG2(µM) | Selectivityd MRSA | SelectivityS. pyogenes |
1 | 5.76 (16) | ND | 0.097 (0.25) | ND | 47 | ND | 3 | 188 |
2 | 0.71 (2) | ND | 0.024 (0.064) | ND | 55 | ND | 28 | 859 |
7 | 0.18 (1) | ND | 0.006 (0.016) | ND | 67 | ND | 67 | 4,187 |
8 | 0.66 (2) | 5.2 (16) | 0.66 (2) | 2.6 (8) | 32 | ND | 16 | 16 |
9 | 0.18 (0.5) | 1.4 (4) | 0.18 (0.5) | 0.72 (2) | 199 | ND | 398 | 398 |
10 | 0.72 (2) | 11.4 (32) | 0.18 (0.5) | 5.7 (16) | 38 | 94 | 19 | 76 |
11 | 0.74 (2) | 11.9 (32) | 0.74 (2) | 6 (16) | 54 | 77 | 27 | 27 |
24 | 0.04 (0.125) | 0.09 (0.25) | 0.04 (0.125) | 0.09 (0.25) | 220 | 233 | 1,760 | 1,760 |
25 | 0.09 (0.5) | ND | 0.012 (0.032) | ND | 85 | 171 | 170 | 2,656 |
26 | 0.02 (0.064) | 0.09 (0.25) | 0.04 (0.125) | 0.09 (0.25) | 217 | 199 | 3,391 | 1,736 |
27 | 0.04 (0.125) | 0.09 (0.25) | 0.04 (0.125) | 0.09 (0.25) | 409 | 465 | 3,272 | 3,272 |
28 | 0.08 (0.25) | 0.16 (0.5) | 0.04 (0.125) | 0.09 (0.25) | 475 | >500 | 1,900 | 3,800 |
31 | 1.5 (4) | 2.94 (8) | 2.94 (8) | 2.94 (8) | 462 | 494 | 116 | 58 |
36 | 0.041 (0.125) | ND | 0.08 (0.25) | ND | >500 | >500 | >4,000 | >2,000 |
37 | 0.16 (0.5) | 0.16 (0.5) | 0.16 (0.5) | 0.16 (0.5) | >500 | ND | >1,000 | >1,000 |
TMP | 0.14 (0.5) | 0.14 (0.5) | 0.58 (2) | 0.58 (2) | ND | ND | ND | ND |
MIC values for MRSA and S. pyogenes are reported in µg/mL (µM).
MIC values for MRSA in the presence of 10% fetal calf serum (FCS) in µg/mL (µM).
MIC values for S. pyogenes in the presence of 10% FCS in µg/mL (µM).
Selectivity values are calculated as IC50 (MCF10)/MIC (pathogen), both values in µM. ND: not determined.